ProNAi Therapeutics Company Profile (NASDAQ:DNAI)

About ProNAi Therapeutics

ProNAi Therapeutics logoProNAi Therapeutics, Inc. is a clinical-stage oncology company. The Company is engaged in business of researching, developing and commercializing therapies for the treatment of patients with cancer and hematological diseases based on its deoxyribonucleic acid interference (DNAi) technology platform. Its lead product candidate includes PNT2258, which targets cancers that overexpress B-cell lymphoma 2 (BCL2), an oncogene known to be dysregulated in various types of cancer. The Company's PNT2258 is a formulation of its single-stranded 24-base DNAi oligonucleotide, known as PNT100, encapsulated in the SMARTICLES Lipid Nanoparticle (LNP). The Company's PNT2258 consists of over two components, including PNT100 DNAi Oligonucleotide and LNP Delivery Technology. It has conducted over two clinical trials for PNT2258, which include a Phase I safety trial in patients with relapsed or refractory solid tumors and a Phase II trial in patients with relapsed or refractory non-Hodgkin's lymphoma (NHL).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: DNAI
  • CUSIP:
Key Metrics:
  • Previous Close: $1.89
  • 50 Day Moving Average: $1.88
  • 200 Day Moving Average: $3.73
  • 52-Week Range: $1.77 - $24.05
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.72
  • P/E Growth: -0.02
  • Market Cap: $57.31M
  • Outstanding Shares: 30,325,000
  • Beta: 1.76
Profitability:
  • Return on Equity: -32.65%
  • Return on Assets: -31.25%
Debt:
  • Current Ratio: 18.94%
  • Quick Ratio: 18.94%
Additional Links:
Companies Related to ProNAi Therapeutics:

Analyst Ratings

Consensus Ratings for ProNAi Therapeutics (NASDAQ:DNAI) (?)
Ratings Breakdown: 3 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $14.83 (684.83% upside)

Analysts' Ratings History for ProNAi Therapeutics (NASDAQ:DNAI)
Show:
DateFirmActionRatingPrice TargetDetails
6/6/2016WedbushDowngradeOutperform -> NeutralView Rating Details
6/6/2016SunTrust Banks Inc.DowngradeBuy -> Neutral$25.00 -> $4.00View Rating Details
6/6/2016Jefferies GroupDowngradeBuy -> Hold$22.00 -> $4.50View Rating Details
8/10/2015Bank of America Corp.Initiated CoverageBuy$35.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for ProNAi Therapeutics (NASDAQ:DNAI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/12/2016Q216($0.38)($0.43)ViewN/AView Earnings Details
5/10/2016Q1($0.42)($0.35)ViewN/AView Earnings Details
3/3/2016Q415($0.58)($0.38)ViewN/AView Earnings Details
11/5/2015Q315($0.48)($11.03)ViewN/AView Earnings Details
8/21/2015Q215($104.10)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ProNAi Therapeutics (NASDAQ:DNAI)
Current Year EPS Consensus Estimate: $-1.32 EPS
Next Year EPS Consensus Estimate: $-1.10 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.54)($0.39)($0.44)
Q2 20163($0.41)($0.37)($0.38)
Q3 20163($0.33)($0.31)($0.32)
Q4 20163($0.31)($0.23)($0.27)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for ProNAi Therapeutics (NASDAQ:DNAI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ProNAi Therapeutics (NASDAQ:DNAI)
Insider Ownership Percentage: 22.20%
Institutional Ownership Percentage: 35.25%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/22/2016Wendy ChapmanSVPSell3,000$7.01$21,030.00View SEC Filing  
2/22/2016Wendy ChapmanSVPSell3,000$7.06$21,180.00View SEC Filing  
1/22/2016Wendi RodiguezainsiderSell3,000$9.86$29,580.00View SEC Filing  
1/22/2016Wendy ChapmanSVPSell5,000$9.39$46,950.00View SEC Filing  
1/15/2016Nicholas GloverCEOSell5,000$10.04$50,200.00View SEC Filing  
1/12/2016Chandra D. LovejoySVPSell20,973$11.29$236,785.17View SEC Filing  
7/21/2015Orbimed Advisors LlcDirectorBuy175,000$17.00$2,975,000.00View SEC Filing  
7/21/2015Vivo Ventures Vii, LlcInsiderBuy220,000$17.00$3,740,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ProNAi Therapeutics (NASDAQ:DNAI)
DateHeadline
streetinsider.com logoPre-Open Stock Movers 09/27: (GI) (KITE) (INFI) Higher; (NAT) (SXL) (RICE) Lower (more...) - StreetInsider.com (NASDAQ:DNAI)
www.streetinsider.com - September 27 at 4:39 PM
News IconShares Spotted Gapping HIgher Pre-Bell: ProNAi Therapeutics, Inc. (NASDAQ:DNAI) - Post News (NASDAQ:DNAI)
www.kentuckypostnews.com - September 27 at 4:39 PM
News IconProNAi Therapeutics Inc. (DNAI), Ballard Power Systems Inc. (USA) (BLDP) & More: Major Hype Surrounding These Stocks Today (NASDAQ:DNAI)
feedproxy.google.com - September 27 at 2:36 PM
News IconUnder the Microscope: Zeroing in on Shares of ProNAi Therapeutics, Inc. (NASDAQ:DNAI) - Duncan Research (NASDAQ:DNAI)
www.duncanindependent.com - September 27 at 9:14 AM
streetinsider.com logoProNAi Therapeutics (DNAI) Obtains PNT737 Development, Commercialization Rights - StreetInsider.com (NASDAQ:DNAI)
www.streetinsider.com - September 27 at 9:14 AM
publicnow.com logoLicence agreement for Chk1 Inhibitor CCT245737 (NASDAQ:DNAI)
www.publicnow.com - September 27 at 9:14 AM
publicnow.com logoProNAi Licenses Oncology Drug Targeting DNA Damage Response Checkpoint Kinase 1 (Chk1) from CRT Pioneer Fund, UK (NASDAQ:DNAI)
www.publicnow.com - September 27 at 9:14 AM
biz.yahoo.com logoPRONAI THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi (NASDAQ:DNAI)
biz.yahoo.com - September 27 at 9:14 AM
News IconUnder the Microscope, Zeroing in at ProNAi Therapeutics, Inc. (NASDAQ:DNAI) - Duncan Research (NASDAQ:DNAI)
www.duncanindependent.com - September 22 at 4:47 PM
News IconConsensus Estimates on Earnings & Stock Price in Focus for ProNAi Therapeutics Inc (NASDAQ:DNAI) Shares - Frisco Fastball (NASDAQ:DNAI)
friscofastball.com - September 22 at 10:12 AM
News IconPenny Stock Investors Take an Interest in ProNAi Therapeutics, Inc. (NASDAQ:DNAI) - Duncan Research (NASDAQ:DNAI)
www.duncanindependent.com - September 21 at 5:09 PM
News IconQ3 2016 EPS Estimates for ProNAi Therapeutics Inc (DNAI) Boosted by Analyst - DailyQuint (NASDAQ:DNAI)
dailyquint.com - September 21 at 5:09 PM
News IconPenny Stock Investors Keen on Shares of ProNAi Therapeutics, Inc. (NASDAQ:DNAI) - Duncan Research (NASDAQ:DNAI)
www.duncanindependent.com - September 21 at 5:09 PM
News IconProNAi Therapeutics Inc (DNAI) Downgraded by Jefferies Group to Hold - DailyQuint (NASDAQ:DNAI)
dailyquint.com - September 20 at 8:23 AM
News IconUnder the Microscope: Getting a Closer Look at Shares of ProNAi Therapeutics, Inc. (NASDAQ:DNAI) - Duncan Research (NASDAQ:DNAI)
www.duncanindependent.com - September 19 at 3:31 PM
News IconPronai Therapeutics Incorporated (NASDAQ:DNAI) Sellers Increased By 13.73% Their Shorts - Post News (NASDAQ:DNAI)
www.kentuckypostnews.com - September 18 at 4:30 PM
News IconKeen Investors Seek Information on ProNAi Therapeutics, Inc. (NASDAQ:DNAI) - Duncan Research (NASDAQ:DNAI)
www.duncanindependent.com - September 17 at 9:23 AM
News IconKeen Investors Narrowing Their Focus on ProNAi Therapeutics, Inc. (NASDAQ:DNAI) - Duncan Research (NASDAQ:DNAI)
www.duncanindependent.com - September 15 at 7:36 AM
News IconPenny Stock Investors Highly Curious in Shares of ProNAi Therapeutics, Inc. (NASDAQ:DNAI) - Duncan Research (NASDAQ:DNAI)
www.duncanindependent.com - September 14 at 8:49 AM
News IconEarnings Analysis & Update for ProNAi Therapeutics Inc (NASDAQ:DNAI)? - Frisco Fastball (NASDAQ:DNAI)
friscofastball.com - September 8 at 8:26 AM
benzinga.com logo(NEOS), ProNAi Therapeutcis, Inc. (NASDAQ:DNAI) - Stocks Hitting ... - Benzinga (NASDAQ:DNAI)
www.benzinga.com - August 29 at 8:48 PM
News IconStock on Trader's Radar: ProNAi Therapeutics, Inc. (NASDAQ:DNAI), YY Inc. (NASDAQ:YY) - Newburg Press (NASDAQ:DNAI)
newburghpress.com - August 23 at 4:46 PM
finance.yahoo.com logoPRONAI THERAPEUTICS INC Financials (NASDAQ:DNAI)
finance.yahoo.com - August 20 at 4:37 PM
News IconProNAi Therapeutics (DNAI) Stock: Here's What You Need To Know - CNA Finance (press release) (NASDAQ:DNAI)
cnafinance.com - August 16 at 4:42 PM
News IconProNAi Therapeutics Inc (NASDAQ:DNAI) to Report Quarterly ... - Post Registrar (NASDAQ:DNAI)
postregistrar.com - August 14 at 9:22 AM
finance.yahoo.com logo7:09 am ProNAi Therapeutics reports Q2 results (NASDAQ:DNAI)
finance.yahoo.com - August 13 at 4:37 PM
finance.yahoo.com logoProNAi Therapeutics Reports Second Quarter 2016 Results (NASDAQ:DNAI)
finance.yahoo.com - August 12 at 4:41 PM
sg.finance.yahoo.com logoProNAi Therapeutics reports 2Q loss (NASDAQ:DNAI)
sg.finance.yahoo.com - August 12 at 8:32 AM
biz.yahoo.com logoPRONAI THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E (NASDAQ:DNAI)
biz.yahoo.com - August 12 at 8:32 AM
News IconStock Update on ProNAi Therapeutics, Inc. (NASDAQ:DNAI) - Duncan Research (NASDAQ:DNAI)
www.duncanindependent.com - August 11 at 10:29 PM
streetupdates.com logoAnalysts Actions to Track: ProNAi Therapeutics, Inc. (NASDAQ:DNAI) , Edwards Lifesciences Corporation (NYSE:EW) - Street Updates (NASDAQ:DNAI)
www.streetupdates.com - August 4 at 4:53 PM
nasdaq.com logoProNAi Therapeutics (DNAI) is Oversold: Can It Recover? - Nasdaq (NASDAQ:DNAI)
www.nasdaq.com - July 29 at 11:40 AM
finance.yahoo.com logoProNAi Therapeutics (DNAI) is Oversold: Can It Recover? (NASDAQ:DNAI)
finance.yahoo.com - July 29 at 9:52 AM
fortune.com logoNoticeable Runners in Pre-Market: Twitter Inc. (NYSE:TWTR ... - Review Fortune (NASDAQ:DNAI)
reviewfortune.com - July 27 at 4:47 PM
News IconAre Analysts Bearish ProNAi Therapeutics Inc (NASDAQ:DNAI) After Last Week? - Consumer Eagle (NASDAQ:DNAI)
www.consumereagle.com - July 23 at 8:46 AM
News IconProNAi Therapeutics Inc (NASDAQ:DNAI): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:DNAI)
www.engelwooddaily.com - July 21 at 10:07 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for ProNAi Therapeutics Inc (NASDAQ:DNAI) - TGP (NASDAQ:DNAI)
telanaganapress.com - July 20 at 9:16 AM
News IconEquity Roundup: Stock Performance Focus on ProNAi Therapeutics Inc (NASDAQ:DNAI) - Press Telegraph (NASDAQ:DNAI)
presstelegraph.com - July 20 at 9:16 AM
fiscalstandard.com logoBroker Outlook For ProNAi Therapeutics, Inc. (DNAI) - Fiscal Standard (NASDAQ:DNAI)
www.fiscalstandard.com - July 20 at 9:16 AM
streetupdates.com logoAnalysts Suggestion Alert: ProNAi Therapeutics, Inc. (NASDAQ:DNAI) , Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) - Street Updates (NASDAQ:DNAI)
www.streetupdates.com - July 19 at 10:47 AM
News IconProNAi Therapeutics Inc (NASDAQ:DNAI)'s Company Shares Decreased 2.43% After Low Volatility - Consumer Eagle (NASDAQ:DNAI)
www.consumereagle.com - July 18 at 4:47 PM
fiscalstandard.com logoProNAi Therapeutics, Inc. (DNAI) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:DNAI)
www.fiscalstandard.com - July 17 at 9:10 AM
news.cmlviz.com logoProNAi Therapeutics Inc Stock Momentum Hits Extreme Weakness - CML News (NASDAQ:DNAI)
news.cmlviz.com - July 16 at 4:32 PM
ftsenews.co.uk logoNew Broker Ratings For ProNAi Therapeutics, Inc. (DNAI) - FTSE News (NASDAQ:DNAI)
www.ftsenews.co.uk - July 15 at 3:39 PM
News IconPronai Therapeutics Incorporated (NASDAQ:DNAI) Shorted Shares Increased 9.52% After Market Selling - Press Telegraph (NASDAQ:DNAI)
presstelegraph.com - July 15 at 8:00 AM
News IconWere Analysts Bearish ProNAi Therapeutics Inc (NASDAQ:DNAI) This Week? - Consumer Eagle (NASDAQ:DNAI)
www.consumereagle.com - July 15 at 8:00 AM
News IconAnalyst Target and Average Rating Watch: ProNAi Therapeutics Inc (NASDAQ:DNAI) - Press Telegraph (NASDAQ:DNAI)
presstelegraph.com - July 14 at 6:19 AM
News IconProNAi Therapeutics Inc (NASDAQ:DNAI) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:DNAI)
telanaganapress.com - July 13 at 9:35 AM
News IconPronai Therapeutics Incorporated (NASDAQ:DNAI) Shorted Shares Increased By 9.52% - Engelwood Daily (NASDAQ:DNAI)
www.engelwooddaily.com - July 10 at 9:10 AM
News IconCompany Stock Focus for ProNAi Therapeutics Inc (NASDAQ:DNAI): Which Way Will Shares Head? - Press Telegraph (NASDAQ:DNAI)
presstelegraph.com - July 7 at 9:51 PM

Social

ProNAi Therapeutics (NASDAQ:DNAI) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff